Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Palonosetron Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114573411B reveals a safer synthesis route for Palonosetron intermediates, eliminating n-hexane and improving purity for reliable pharmaceutical intermediates supplier partnerships.
Patent CN107382697A details efficient chiral resolution for Palonosetron intermediate, ensuring high purity and supply stability for pharmaceutical manufacturing.